Brief: OncoSec Reports FDA Approval To Begin Clinical Trial Of COVID-19 Vaccine Candidate
29/10/2020 13:49
Oct 29 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR
INITIATION OF PHASE 1 CLINICAL TRIAL OF ITS CORVAX12 VACCINE
CANDIDATE FOR COVID-19
* ONCOSEC MEDICAL - FDA HAS APPROVED IND APPLICATION FOR A
FIRST-IN-HUMAN PHASE 1 TRIAL FOR CORVAX12
Source text for Eikon: ID:nPn8H3kZwa
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq